Stocks

The table gives an overview of all stocks, alphabetically sorted.
 Xact Bear XACTBEAR Apr 1, 2020 55.92 +5.21   
 Xact Bear 2 XACTBEAR2 Apr 1, 2020 44.20 +7.06   
 Xact Bull XACTBULL Apr 1, 2020 324.00 -4.99   
 Xact Bull 2 XACTBULL2 Apr 1, 2020 567.50 -6.86   
 XACT Högutdelande XACTHDIV Apr 1, 2020 107.44 -0.17   
 Xact OMXS30 XACTOMXS30 Apr 1, 2020 179.78 -2.79   
 XANO Industri B XANOB Apr 1, 2020 79.00 -3.66   
 Xavitech B XAVIB Apr 1, 2020 1.06 -15.20   
 Xbrane Biopharma XBRANE Apr 1, 2020 31.90 +0.63   
 Xintela XINT Apr 1, 2020 3.60 +4.35   
 XMReality XMR Apr 1, 2020 2.17 -2.25   
 Xspray Pharma XSPRAY Apr 1, 2020 54.20 0.00   
 Xvivo Perfusion XVIVO Apr 1, 2020 96.00 -3.13   
 XXL XXLO Apr 1, 2020 8.85 0.00   
 Yara International YARO Apr 1, 2020 338.30 +4.09   
 Zaplox ZAPLOX Apr 1, 2020 0.69 +7.59   
 Zenergy B ZENZIPB Apr 1, 2020 0.33 -3.47   
 Zenicor ZENI Apr 1, 2020 10.00 +17.65   
 ZetaDisplay ZETA Apr 1, 2020 14.50 +0.35   
 Ziccum ZICC Apr 1, 2020 13.70 -0.72   
 ZignSec ZIGN Apr 1, 2020 7.25 +1.54   
 Zinzino B ZZB Apr 1, 2020 20.00 +1.52   
 Zoomability ZOOM Apr 1, 2020 3.66 0.00   
 Zordix B ZORDIXB Apr 1, 2020 7.24 +2.55   
 Zutec ZUTEC Apr 1, 2020 1.26 -14.29   
 Zwipe ZWIPE Apr 1, 2020 3.17 0.00   
 ÅF Pöyry B AFB Apr 1, 2020 146.10 -4.07   
 Öresund ORES Apr 1, 2020 100.20 -4.57   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK